https://www.selleckchem.com/pr....oducts/Rutin(Rutosid
The high mortality rate of decompensated cirrhosis underlines the need for new treatments. Experimental models of cirrhosis and its reported relationship with atherosclerotic cardiovascular disease have provided data supporting the rational use of statins in these patients. However, little is known about the safety of statins in this setting. We evaluate the safety of chronic simvastatin treatment in patients with decompensated cirrhosis. We conducted a prospective, open, uncontrolled, phase 2a trial in 30 patients with Child-Pu
Like
Comment
Share
